Hayashi T, Sudo J
Department of Toxicology and Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Higashi-Nippon-Gakuen University, Hokkaido, Japan.
J Toxicol Sci. 1992 May;17(2):31-9. doi: 10.2131/jts.17.31.
To comparably investigate hemotoxic potentials of CdCl2, cadmium-saturated metallothioneins-I (Cd-MT-I) and -II (Cd-MT-II), rats received single intravenous injections of one of those dissolved in saline with equivalent concentrations of Cd (0, 0.1, 0.3 and 1.0 mg Cd/kg body weight), and blood for hematological examinations was sampled at 1 and 5 days (Days 1 and 5) after the administrations. The counts of white blood cells showed dose-dependent increments in the 0.3 and 1.0 mg Cd/kg groups in Cd-MT-I and Cd-MT-II at Day 1, and returned to the normal levels at Day 5. The counts of platelets showed dose-dependent decrements in the three-doses groups of Cd-MT-I and Cd-MT-II at Day 1, and did a returning- and further increasing tendency at Day 5. The counts of red blood cells, values of hematocrit, hemoglobin, mean corpuscular volume, mean corpuscular hemoglobin and mean corpuscular hemoglobin concentration, showed only slight and sporadic changes at Days 1 and 5. As to that thrombocytopenia and leukocytosis were dose-dependently brought by Cd-MTs and not by CdCl2, and as to that CdCl2 and Cd-MTs hardly affected erythrocytes regarding their counts, sizes, hemoglobin contents etc., etiological mechanism (s) remains to be explored. However, our findings should be clinically emphasized in relation to Itai-Itai disease and Cd-intoxication.
为了比较研究氯化镉、镉饱和金属硫蛋白-I(Cd-MT-I)和-II(Cd-MT-II)的血液毒性潜力,大鼠单次静脉注射溶解于生理盐水中的上述物质之一,镉浓度等效(0、0.1、0.3和1.0毫克镉/千克体重),给药后第1天和第5天(第1天和第5天)采集血液进行血液学检查。第1天,Cd-MT-I和Cd-MT-II的0.3和1.0毫克镉/千克组白细胞计数呈剂量依赖性增加,第5天恢复到正常水平。第1天,Cd-MT-I和Cd-MT-II的三个剂量组血小板计数呈剂量依赖性减少,第5天呈恢复和进一步增加趋势。红细胞计数、血细胞比容值、血红蛋白、平均红细胞体积、平均红细胞血红蛋白和平均红细胞血红蛋白浓度在第1天和第5天仅出现轻微和零星变化。由于Cd-MTs而非氯化镉剂量依赖性地导致血小板减少和白细胞增多,并且由于氯化镉和Cd-MTs在红细胞计数、大小、血红蛋白含量等方面几乎不产生影响,病因机制仍有待探索。然而,就痛痛病和镉中毒而言,我们的研究结果应在临床上予以重视。